NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Vercise™ DBS Dystonia Prospective Study

RecruitingN/A

Sponsor: Boston Scientific Corporation

Conditions: Dystonia

Interventions: Deep Brain Stimulation (DBS)

Countries: Belgium, Canada, Germany, Hungary, Israel, Italy, Netherlands, Poland

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

Eligibility overview

Sex: ALL

Age: 7 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria (IC):

* IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia.
* IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent.

Exclusion Criteria (EC):

* EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use.

Locations (36)

Ghent, Belgium
Leuven, Belgium
Halifax, Canada
Berlin, Germany
Cologne, Germany
Düsseldorf, Germany
Freiburg im Breisgau, Germany
Hamburg, Germany
Hamm, Germany
Hanover, Germany
Kiel, Germany
Mainz, Germany
Marburg, Germany
Oldenburg, Germany
Würzburg, Germany
Pécs, Hungary
Jerusalem, Israel
Ferrara, Italy
Mestre, Italy
Rome, Italy
Udine, Italy
The Hague, Netherlands
Bydgoszcz, Poland
Bydgoszcz, Poland
Gdansk, Poland
Warsaw, Poland
Moscow, Russia
Incheon, South Korea
Barcelona, Spain
El Palmar, Spain
+ 6 more on CT.gov